Cortrosyn

Iritis, Ophthalmia, Sympathetic, Pemphigus + 22 more

Treatment

43 FDA approvals

0 Active Studies for Cortrosyn

What is Cortrosyn

Tetracosactide

The Generic name of this drug

Treatment Summary

Tetracosactide (also known as Cosyntropin) is a synthetic hormone that is identical to a segment of the natural hormone adrenocorticotropic hormone (ACTH). This peptide works in the same way as natural ACTH, stimulating the production of corticosteroids in the adrenal cortex. Tetracosactide is absorbed over a longer period of time than natural ACTH, so treatment can be continued with less frequent doses.

Cortrosyn

is the brand name

image of different drug pills on a surface

Cortrosyn Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cortrosyn

Tetracosactide

2003

10

Approved as Treatment by the FDA

Tetracosactide, also known as Cortrosyn, is approved by the FDA for 43 uses which include Jaundice, Hemolytic and Dermatomyositis .

Jaundice, Hemolytic

Helps manage acquired hemolytic jaundice

Dermatomyositis

Helps manage Dermatomyositis (DM)

Nephrotic Syndrome

Helps manage Nephrotic Syndrome

Rheumatoid Arthritis

Helps manage Rheumatoid Arthritis

acquired hemolytic jaundice

Helps manage acquired hemolytic jaundice

Choroiditis

Helps manage Choroiditis

Ophthalmia, Sympathetic

Helps manage Ophthalmia, Sympathetic

Keratitis

Helps manage Keratitis

Ulcerative Colitis

Helps manage Ulcerative Colitis

Ankylosing Spondylitis (AS)

Helps manage Ankylosing Spondylitis (AS)

Still's Disease

Helps manage Still's Disease

Multiple sclerosis exacerbation

Helps manage Multiple sclerosis exacerbation

Bell's Palsy

Helps manage Bell's Palsy

Periarteritis nodosa

Helps manage Periarteritis nodosa

Choroiditis

Helps manage Choroiditis

Pink Eye

Helps manage Conjunctivitis

Adrenal Insufficiency

Pemphigus

Helps manage Pemphigus

exfoliative erythroderma

Helps manage exfoliative erythroderma

Dermatomyositis (DM)

Helps manage Dermatomyositis (DM)

Ankylosing Spondylitis

Helps manage Ankylosing Spondylitis (AS)

Ulcerative Colitis

Helps manage Ulcerative Colitis

Arthritis, Juvenile

Helps manage Still's Disease

Uveitis

Helps manage Uveitis

Iritis

Helps manage Iritis

Acute Gouty Arthritis

Panhypopituitarism

Helps manage Panhypopituitarism

Conjunctivitis

Helps manage Conjunctivitis

Optic Neuritis

Helps manage Optic Neuritis

Acute Rheumatic Fever

Helps manage Acute Rheumatic Fever

Bell Palsy

Helps manage Bell's Palsy

Adrenal gland hypofunction

Pemphigus

Helps manage Pemphigus

Uveitis

Helps manage Uveitis

Scleroderma

Helps manage Scleroderma

Hypopituitarism

Helps manage Panhypopituitarism

Rheumatic Fever

Helps manage Acute Rheumatic Fever

Multiple Sclerosis

Helps manage Multiple sclerosis exacerbation

Arthritis, Gouty

Lupus Erythematosus

Helps manage Lupus Erythematosus

Optic Neuritis

Helps manage Optic Neuritis

Psoriatic Arthritis

Helps manage Psoriatic Arthritis

Iritis

Helps manage Iritis

Effectiveness

How Cortrosyn Affects Patients

Cosyntropin is a synthetic form of ACTH (adrenocorticotropic hormone) that has similar effects to natural ACTH, with the potential to stimulate the adrenal cortex. The effects of Cosyntropin are maximized at 0.25 milligrams (mg) and are comparable to the effects of 25 units of natural ACTH. Cosyntropin is less likely to cause an allergic reaction than natural ACTH, as it lacks part of the amino acid sequence that is responsible for causing an immune response. In addition to stimulating the adrenal cortex, Cosyntropin may also increase melanin production and

How Cortrosyn works in the body

Cosyntropin connects to a receptor on the cells in the adrenal gland. This connection stimulates the production of hormones, like cortisol and aldosterone, from cholesterol. In people with healthy adrenal glands, cosyntropin increases the amount of hormones produced. However, it won't have much effect on those with adrenal insufficiency.

When to interrupt dosage

The endorsed portion of Cortrosyn is contingent upon the diagnosed condition, including Exfoliative dermatitis, Arthritis, Gouty and Uveitis. The dosage fluctuates based on the method of administration (e.g. Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral or Injection, solution) as seen in the table below.

Condition

Dosage

Administration

Ophthalmia, Sympathetic

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Pemphigus

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Uveitis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Pink Eye

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Jaundice, Hemolytic

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Periarteritis nodosa

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Hypopituitarism

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Multiple Sclerosis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

exfoliative erythroderma

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Arthritis, Gouty

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Dermatomyositis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Optic Neuritis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Adrenal Insufficiency

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Ulcerative Colitis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Rheumatoid Arthritis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Bell Palsy

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Ankylosing Spondylitis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Rheumatic Fever

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Arthritis, Juvenile

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Iritis

, 0.25 mg/mL, 0.25 mg, 1.0 mg/mL

, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intramuscular; Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intramuscular; Intravenous, Powder, for solution, Powder, for solution - Intramuscular; Intravenous, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intramuscular, Suspension - Intramuscular, Suspension, Intramuscular; Intravenous; Parenteral, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous; Parenteral, Injection, solution, Injection, solution - Intravenous

Warnings

Cortrosyn has twelve contraindications and should not be employed when experiencing any of the conditions appearing in the following table.

Cortrosyn Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Hypersensitivity

Do Not Combine

Mycoses

Do Not Combine

Virus Diseases

Do Not Combine

Cushing Syndrome

Do Not Combine

Adrenogenital Syndrome

Do Not Combine

Congestive heart failure

Do Not Combine

Peptic Ulcer

Do Not Combine

Addison Disease

Do Not Combine

Psychotic Disorders

Do Not Combine

Pulse Frequency

Do Not Combine

Bacterial Infections

Do Not Combine

There are 20 known major drug interactions with Cortrosyn.

Common Cortrosyn Drug Interactions

Drug Name

Risk Level

Description

Valproic acid

Major

Tetracosactide may increase the hepatotoxic activities of Valproic acid.

7-Nitroindazole

Moderate

The risk or severity of liver damage can be increased when Tetracosactide is combined with 7-Nitroindazole.

Acetazolamide

Moderate

The risk or severity of liver damage can be increased when Tetracosactide is combined with Acetazolamide.

Amobarbital

Moderate

The risk or severity of liver damage can be increased when Tetracosactide is combined with Amobarbital.

Barbexaclone

Moderate

The risk or severity of liver damage can be increased when Tetracosactide is combined with Barbexaclone.

image of a doctor in a lab doing drug, clinical research

Cortrosyn Novel Uses: Which Conditions Have a Clinical Trial Featuring Cortrosyn?

222 active trials are currently being conducted to determine the potential of Cortrosyn in alleviating symptoms of Choroiditis, Multiple Sclerosis and Sympathetic Ophthalmia.

Condition

Clinical Trials

Trial Phases

Pink Eye

0 Actively Recruiting

Dermatomyositis

0 Actively Recruiting

Rheumatoid Arthritis

54 Actively Recruiting

Not Applicable, Phase 4, Phase 3, Phase 2, Phase 1

Ophthalmia, Sympathetic

0 Actively Recruiting

Pemphigus

0 Actively Recruiting

Bell Palsy

0 Actively Recruiting

Multiple Sclerosis

0 Actively Recruiting

exfoliative erythroderma

0 Actively Recruiting

Lupus Erythematosus

3 Actively Recruiting

Phase 4, Phase 1, Not Applicable

Nephrotic Syndrome

5 Actively Recruiting

Phase 2, Not Applicable, Phase 3

Psoriatic Arthritis

29 Actively Recruiting

Phase 3, Not Applicable, Phase 1, Phase 4, Phase 2

Uveitis

3 Actively Recruiting

Not Applicable, Phase 3

Ankylosing Spondylitis

3 Actively Recruiting

Phase 3, Not Applicable

Scleroderma

10 Actively Recruiting

Not Applicable, Phase 2, Phase 3, Phase 1

Arthritis, Gouty

0 Actively Recruiting

Ulcerative Colitis

14 Actively Recruiting

Phase 3, Phase 2, Not Applicable, Phase 4, Phase 1

Rheumatic Fever

0 Actively Recruiting

Periarteritis nodosa

0 Actively Recruiting

Jaundice, Hemolytic

0 Actively Recruiting

Choroiditis

0 Actively Recruiting

Cortrosyn Reviews: What are patients saying about Cortrosyn?

3

Patient Review

8/25/2012

Cortrosyn for Problem with Adrenal Gland

The injection was quite painful and it left a really unpleasant taste in my mouth.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about cortrosyn

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why is Cortrosyn given?

"Cortrosyn can be administered in different ways depending on what it is being used for. It can be given as an intramuscular injection or as a direct intravenous injection for a quick test of adrenal function. It can also be given as an intravenous infusion over a period of 4 to 8 hours to provide a greater stimulus to the adrenal glands."

Answered by AI

What does Cortrosyn treat?

"Cortrosyn is a man-made version of a natural substance made by the body called ACTH. It is used to diagnose problems with the adrenal gland, such as Addison's disease or insufficiency caused by corticosteroid use. Cortrosyn is available in generic form."

Answered by AI

What kind of drug is Cortrosyn?

"Cortrosyn is a prescription medicine used as a diagnostic tool for adrenocortical insufficiency. Cortrosyn may be used alone or with other medications. Cortrosyn belongs to a class of drugs called diagnostic tools, specifically for endocrine conditions."

Answered by AI

What is cosyntropin used for?

"Cosyntropin is a man-made copy of a hormone that is used to test patients for adrenal gland problems. This testing is the best way to diagnose adrenal gland problems."

Answered by AI